Print

Family Communication After Genetic Testing for Colorectal Cancer

https://www.facingourrisk.org/research-clinical-trials/study/437 /family-communication-after-genetic-testing-for-colorectal-cancer

Clinicaltrials.gov identifier:
NCT07143487 (https://clinicaltrials.gov/show/NCT07143487)

Prevention
People with newly diagnosed colorectal cancer communicate genetic testing information to their first-degree relatives

Study Contact Information:

Study Contact: Rachel Wills
Phone: 773-702-9814
Email: [email protected]


About the Study

Some people with colorectal cancer have an inherited genetic change that can increase the risk of colorectal and other cancers. When a person is found to have one of these inherited changes, their close relatives may also have an increased risk and may benefit from genetic testing.

This study is looking at different ways of helping family members learn about their potential inherited cancer risk and access genetic testing.

The study will compare two approaches:

  1. The person with colorectal cancer tells their close family members about their genetic test results and encourages them to have genetic testing.
  2. A member of the healthcare/research team contacts the family members directly to explain the genetic testing opportunity and help them access testing.

Researchers want to learn which approach is more effective at helping first-degree relatives understand their potential cancer risk and complete genetic testing.

What the Study Involves

The study has two main steps.

Step 1: Genetic testing

Step 2: Family genetic testing

Group A — Patient-mediated communication:
 The person with colorectal cancer communicates the genetic test information to their family members and encourages them to pursue genetic testing.

Group B — Provider-mediated communication:
 A member of the healthcare/research team contacts the family member directly to explain the genetic testing opportunity and help with the process.

Researchers will compare the two approaches to see how they affect genetic testing among family members. The initial patient will be followed for up to three years, while participating family members will be followed for up to one year.

Why Is This Study Important?

When someone has an inherited cancer-risk gene change, their first-degree relatives—such as their parents, siblings, and children—may have a chance of carrying the same change.

However, it can be difficult for patients to explain complicated genetic information to their relatives. Some family members may not understand why genetic testing is important, while others may not know how to arrange testing.

This study is examining whether having a healthcare provider communicate directly with relatives can make it easier for them to understand their potential inherited cancer risk and obtain genetic testing.

What Researchers Hope to Learn

Researchers will study:


This Study is Open To:

People with newly diagnosed colorectal cancer:

Family members:

First-degree relatives who participate must:

This Study is Not Open To:

You may not qualify if: 


About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.